Insider · CIK 0002050167
Atul Dandekar
Files at: MAZE. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | Maze Therapeutics, Inc.MAZE | 6,434 | $26.24 | $168,811 | 32,316 | −16.6% | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:29 pm EDT | Maze Therapeutics, Inc.MAZE | 12,500 | — | — | 38,750 | — | |
| Aug 28, 2026 SForm 4 → | Aug 31, 6:32 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $27.58 | $206,824 | 26,250 | −22.2% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 31, 6:32 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $10.42 | $78,150 | 33,750 | — | 10b5-1 |
| Jul 29, 2026 SForm 4 → | Jul 31, 4:15 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $27.34 | $205,031 | 26,250 | −22.2% | 10b5-1 |
| Jul 29, 2026 MForm 4 → | Jul 31, 4:15 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $10.42 | $78,150 | 33,750 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jul 1, 4:17 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $28.02 | $210,150 | 26,250 | −22.2% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 4:17 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | $10.42 | $78,150 | 33,750 | — | 10b5-1 |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 4:29 pm EDT | Maze Therapeutics, Inc.MAZE | 12,500 | — | — | 12,500 | — | |
| Aug 28, 2026 MForm 4 → | Aug 31, 6:32 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | — | — | 14,143 | — | 10b5-1 |
| Jul 29, 2026 MForm 4 → | Jul 31, 4:15 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | — | — | 21,643 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 4:17 pm EDT | Maze Therapeutics, Inc.MAZE | 7,500 | — | — | 29,143 | — | 10b5-1 |